Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Similar articles for PubMed (Select 22505851)

1.

Open clinical trial data for all? A view from regulators.

Eichler HG, Abadie E, Breckenridge A, Leufkens H, Rasi G.

PLoS Med. 2012;9(4):e1001202. doi: 10.1371/journal.pmed.1001202. Epub 2012 Apr 10. No abstract available.

2.

The imperative to share clinical study reports: recommendations from the Tamiflu experience.

Doshi P, Jefferson T, Del Mar C.

PLoS Med. 2012;9(4):e1001201. doi: 10.1371/journal.pmed.1001201. Epub 2012 Apr 10. No abstract available.

3.

Why don't we have all the evidence on oseltamivir?

Godlee F, Clarke M.

BMJ. 2009 Dec 8;339:b5351. doi: 10.1136/bmj.b5351. No abstract available. Erratum in: BMJ. 2010;340:c405.

PMID:
19995815
4.

What can we learn from observational studies of oseltamivir to treat influenza in healthy adults?

Freemantle N, Calvert M.

BMJ. 2009 Dec 8;339:b5248. doi: 10.1136/bmj.b5248. Review. No abstract available.

PMID:
19995814
5.

UK regulators deny claims that their access to oseltamivir trial data was insufficient.

O'Dowd A.

BMJ. 2013 Jun 18;346:f3966. doi: 10.1136/bmj.f3966. No abstract available.

PMID:
23778580
6.

Complications: tracking down the data on oseltamivir.

Cohen D.

BMJ. 2009 Dec 8;339:b5387. doi: 10.1136/bmj.b5387. No abstract available. Erratum in: BMJ. 2010;340:c406.

PMID:
19995818
7.

Data sharing will pay dividends.

[No authors listed]

Nature. 2014 Jan 9;505(7482):131. No abstract available.

PMID:
24409508
8.

Neuraminidase inhibitors--the story behind the Cochrane review.

Doshi P.

BMJ. 2009 Dec 8;339:b5164. doi: 10.1136/bmj.b5164. No abstract available.

PMID:
19995813
9.

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).

Brettschneider C, Lühmann D, Raspe H.

GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.

10.

Bone graft substitutes for the treatment of traumatic fractures of the extremities.

Hagen A, Gorenoi V, Schönermark MP.

GMS Health Technol Assess. 2012;8:Doc04. doi: 10.3205/hta000102. Epub 2012 Jun 14.

11.

Unblinding plan of PROWESS-SHOCK trial.

Ranieri VM, Thompson BT, Finfer S, Barie PS, Dhainaut JF, Douglas IS, Gårdlund B, Marshall JC, Rhodes A; PROWESS-SHOCK Academic Steering Committee.

Intensive Care Med. 2011 Aug;37(8):1384-5. doi: 10.1007/s00134-011-2272-7. Epub 2011 Jun 21. No abstract available.

PMID:
21691888
12.

Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.

Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R, Nicholson K.

Health Technol Assess. 2009 Feb;13(11):iii, ix-xii, 1-246. doi: 10.3310/hta13110. Review.

13.

Cochrane group rejects Roche's offer of "advisory board" to discuss analysis of oseltamivir data.

Kmietowicz Z.

BMJ. 2012 Nov 26;345:e8072. doi: 10.1136/bmj.e8072. No abstract available.

PMID:
23183073
14.

Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.

Shun-Shin M, Thompson M, Heneghan C, Perera R, Harnden A, Mant D.

BMJ. 2009 Aug 10;339:b3172. doi: 10.1136/bmj.b3172. Review.

15.

We need access to all data from all clinical trials.

Gøtzsche PC.

Cochrane Database Syst Rev. 2011 Oct 4;(12):ED000035. doi: 10.1002/14651858.ED000035. No abstract available.

PMID:
22161455
16.

Ethical issues with the disclosure of surgical trial short-term data.

Allardyce RA, Bagshaw PF, Frampton CM, Frizelle FA, Hewett PJ, Rieger NA, Smith JS, Solomon MJ, Stevenson AR.

ANZ J Surg. 2011 Mar;81(3):125-31. doi: 10.1111/j.1445-2197.2010.05433.x. Epub 2010 Aug 16.

PMID:
21342382
17.

From therapeutic trials to current practice.

van Gijn J.

Rev Neurol (Paris). 1999;155(9):708-12. Review.

PMID:
10528354
18.

Roche offers researchers access to all Tamiflu trials.

Cohen D.

BMJ. 2013 Apr 4;346:f2157. doi: 10.1136/bmj.f2157. No abstract available.

PMID:
23558407
19.

Using Cochrane reviews for oral diseases.

Worthington HV, Glenny AM, Mauleffinch LF, Daly F, Clarkson J.

Oral Dis. 2010 Oct;16(7):592-6. doi: 10.1111/j.1601-0825.2010.01674.x.

PMID:
20846149
20.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.

Jefferson T, Jones M, Doshi P, Del Mar C.

BMJ. 2009 Dec 8;339:b5106. doi: 10.1136/bmj.b5106. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk